论文部分内容阅读
目的观察纳米银抗菌水凝胶联合特拉唑嗪治疗Ⅲa型前列腺炎的临床疗效。方法选取我院84例门诊Ⅲa前列腺炎患者,将其随机分为两组,治疗组选用纳米银抗菌水凝胶联合特拉唑嗪进行治疗,对照组选用左氧氟沙星联合特拉唑嗪进行治疗,治疗4周后按美国国立卫生院慢性前列腺炎症状评分(NIH-CPSI)和前列腺液白细胞计数(EPS-WBC)分类评估疗效。结果 NIH-CPSI评分:治疗组有效率为80.9%,对照组为64.3%;EPS-WBC分类:治疗组有效率为78.6%,对照组为59.5%。治疗组优于对照组(P<0.05)。结论纳米银抗菌水凝胶治疗Ⅲa型前列腺炎有较好的临床效果,可广泛应用。
Objective To observe the clinical efficacy of nano-silver antibacterial hydrogel combined with terazosin in the treatment of type Ⅲa prostatitis. Methods Eighty-four outpatients with Ⅲa prostatitis in our hospital were selected and randomly divided into two groups. The treatment group was treated with nano-silver antibacterial hydrogel combined with terazosin, and the control group was treated with levofloxacin and terazosin. After 4 weeks, the curative effect was evaluated according to the National Institutes of Health Chronic Prostat Symptom Score (NIH-CPSI) and the prostatic fluid leukocyte count (EPS-WBC) classification. Results The NIH-CPSI score was 80.9% in the treatment group and 64.3% in the control group. The classification of EPS-WBC was 78.6% in the treatment group and 59.5% in the control group. The treatment group was better than the control group (P <0.05). Conclusion nano-silver antibacterial hydrogel treatment of type Ⅲ a prostatitis has a good clinical effect, can be widely used.